FundedIQ
Biotechnology

Rybodyn: Funding, Investors & Team (Oct 2026)

Rybodyn is a biotechnology research company that develops therapeutics to train the immune system to detect and eradicate cancer internally.

www.rybodyn.com LinkedIn San Diego, United States 11-50 employees
Biotechnology Medical Pharmaceutical Therapeutics
Total raised
$10.0M
Rounds
1
Latest
Seed
Mar 2026

Rybodyn has raised $10.0M across 1 funding round on record, the most recent a Seed of $10.0M announced in Mar 2026.

That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Rybodyn Company Profile and Key Stats

Total funding raised
$10.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Seed
$10.0M in Mar 2026
Employees
11-50
reported band
Headquarters
San Diego, United States

Latest funding round on record: Mar 2026.

Rybodyn Funding Rounds

Date
Round
Amount
Seed
$10.0M

Rybodyn Founders and Leadership Team

Name
Role
Contact
Imad Ajjawi
Founder
Locked

Contact details for the Rybodyn team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.

Start 14-day free trial →

Rybodyn Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
30,234
$7.6M
17,054
$3.1M

Rybodyn's latest round of $10.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Rybodyn in Biotechnology and San Diego

Companies Similar to Rybodyn

Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

Rybodyn Funding FAQs

What does Rybodyn do?

Rybodyn is a biotechnology research company that develops therapeutics to train the immune system to detect and eradicate cancer internally.

How much funding has Rybodyn raised?

Rybodyn has raised $10.0M across 1 round on record. The most recent is a Seed of $10.0M announced in Mar 2026.

When did Rybodyn last raise funding?

Rybodyn's most recent funding round on record is a Seed of $10.0M, announced in Mar 2026.

Who founded Rybodyn?

FundedIQ lists Imad Ajjawi (Founder) at Rybodyn.

Where is Rybodyn headquartered?

Rybodyn is based in San Diego, California, United States.

How many employees does Rybodyn have?

Rybodyn is in the 11-50 employee band.

How does Rybodyn's funding compare to other Biotechnology startups?

Rybodyn's latest round of $10.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Rybodyn Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Rybodyn is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.